|
Hongrui Liu, Associate Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Cardiovascular | Pharmacology | Heart | Blood Vessels | Drugs | Cancer | Tumor | Chemotherapy | Apoptosis | Cell Cycle |
|
Wenfu Tan, Researcher
Fudan University, Pharmaceutical Sciences
Area of Focus
Anti-Tumor | Drug Activity | In Vitro | In Vivo | Evaluation | Molecular Targeted | Drug Development | Pharmacology | Cancer | Therapy |
|
Hongbo Weng, Associate Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Diabetes | Pharmacology | Drug Research | Anti-Diabetic | Mechanism Study | Complement Inhibitors | Lupus | Molecular Biology | Immunology | Hypertension |
|
Meidan Ying, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Tumor | Pharmacology | Cancer | Drug Targets | Pediatric | Malignant | Innovative Drugs | Research | Mechanisms | Regulation |
|
Xiaoyuan Lian, Professor | Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Traditional Chinese Medicine | Pharmacology | Neuropharmacology | New Drug Development | Ginsenosides | Parkinson'S Disease | Epilepsy | Cancer | Stem Cells | Neuroprotection |
|
Yichen Xu, Hundred Talents Program Researcher, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Tumor | Pharmacology | Mrna | Translation | Regulation | Mechanism | Drug | Targeting | Cancer | Therapy |
|
Hao-Shu Wu, Associate Professor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Pharmacology | Drug Development | Therapeutics | Pharmaceutical Education | Innovative Teaching | Research Training | Diabetes | Lipid Metabolism | Insulin Sensitization | Glp-1 |
|
Xuejing Shao, Distinguished Researcher
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Cancer | Pharmacology | Leukemia | Fusion Proteins | Drug Targets | Tumor Cell Differentiation | Innovative Drugs | Therapeutic Strategies | Post-Translational Modifications | Small Molecule Drugs |
|
Xiangbao Meng, Professor
Peking University , Pharmaceutical Sciences
Area of Focus
Immunomodulators | Small Molecules | Anti-Inflammatory | Drug Discovery | Optimization | Multi-Target | Drug-Resistant Tumors | Cancer | Inflammation | Immune Regulation |
|
Hong Liang, Professor, Doctoral Supervisor
Peking University , Pharmaceutical Sciences
Area of Focus
Natural Products | Bioactivity | Structure | Traditional Chinese Medicine | Quality Analysis | Hplc | Fingerprinting | Chemical Compounds | Inflammation | Cancer |
